Specialty Pharmacy

Disrupting the circadian rhythm exacerbate multiple sclerosis symptoms.

Top news of the day from across the health care landscape.

Children with HIV have a unique risk of nonadherence in adolescence and elevated risk of mental health and substance use problems later in life.

Patients with multiple sclerosis who eat healthy could reduce their risk of severe disability by 20%.

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses how stakeholder alliances benefit patients.

Only 21% of HIV-positive individuals visited a health care provider within 2 weeks of release from jail or prison.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

Vaccine regimen based on mosaic immunogens designed to create a buffer against various strains of HIV.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

An immunotherapy combination increased progression-free survival among patients with advanced renal cell carcinoma.

A combination of ramucirumab plus cisplatin and capecitabine did not improve survival in gastric cancer.

Increasing myelin production by targeting oligodendrocytes shows promise as a treatment for multiple sclerosis.

Voluntary male circumcision and starting antiretroviral therapy reduced new cases of HIV by 42% in vulnerable regions.

Top news of the day from across the health care landscape.

THC found to slow the process of neurodegeneration, which affects nearly half of all patients with HIV.

Prescription drug list prices outpaced the rate of inflation every year from 2006 to 2015.

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, highlights emerging trends in the specialty pharmacy landscape.

Tisagenlecleucel (Kymriah) produced an overall response rate of 53% in patients with lymphoma.

Long-acting pre-exposure prophylaxis may improve adherence to HIV treatment.

Liver cancer is the most common cancer caused by diabetes and obesity.

Top news of the day from across the health care landscape.

Treating aging patients with immunomodulatory drugs further increases the risk of infections.

A proposed Sandoz biosimilar of pegfilgrastim (Neulasta) demonstrated biosimilarity to the reference biologic.

A high number of patients with eosinophilic granulomatosis treated with mepolizumab achieve remission within 24 weeks compared with placebo patients.

Patients taking hydrochlorothiazide may be 7 times more likely to develop squamous cell carcinoma.

The presence of a nerve protein in the blood may indicate the development of new T1 and T2 lesions resulting from multiple sclerosis.

These findings could lead to novel a HIV vaccine.